Peter M. Strumph serves as Executive at Nile Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Peter M. Strumph has executed 10 insider transactions totaling $11.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 1, 2012 involved receiving (via award) 3,300 shares valued at $0.
Peter M. Strumph currently holds 60,756 shares of Nile Therapeutics, Inc. (NILT.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter M. Strumph has been a net buyer of NILT.OB stock. They have purchased $11.3K and sold $0 worth of shares.
Peter M. Strumph's most recent insider trade was on Jun 1, 2012, when they sold 3,300 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2012 | CDXS | $0 | Award | 2,739 | $N/A | Discretionary |
| Mar 7, 2012 | CDXS | $0 | Award | 32,000 | $N/A | Discretionary |
| Dec 12, 2008 | NLTX | $1.6K | Purchase | 2,000 | $0.79 | Discretionary |
| Dec 12, 2008 | NLTX | $1.0K | Purchase | 1,000 | $1.00 | Discretionary |
| Dec 11, 2008 | NLTX | $2.1K | Purchase | 3,580 | $0.60 | Discretionary |
| Apr 14, 2008 | NILT.OB | $940 | Purchase | 200 | $4.70 | Discretionary |
| Apr 14, 2008 | NILT.OB | $940 | Purchase | 200 | $4.70 | Discretionary |
| Apr 14, 2008 | NILT.OB | $4.7K | Purchase | 1,000 | $4.70 | Discretionary |